High risk surveillance MRI may not be necessary in BRCA1/2 mutation carriers over 70 years old
Astrid Botty van den Bruele, Yi Ren, Samantha M. Thomas, Koumani W. Ntowe, Laura H. Rosenberger, Carolyn Menendez, Lars J. Grimm, Akiko Chiba, Jennifer K. Plichta
Springer Nature ·
2025-02-27
· DOI 10.1007/s10549-025-07657-y
Аннотация у издателя не опубликована — полный текст доступен по ссылке ниже.
Astrid Botty van den Bruele, Yi Ren, Samantha M. Thomas, Koumani W. Ntowe, Laura H. Rosenberger, Carolyn Menendez et al. High risk surveillance MRI may not be necessary in BRCA1/2 mutation carriers over 70 years old. // Breast Cancer Research and Treatment. – 2025. – DOI: 10.1007/s10549-025-07657-y. – URL: https://doi.org/10.1007/s10549-025-07657-y
Astrid Botty van den Bruele, Yi Ren, Samantha M. Thomas, Koumani W. Ntowe, Laura H. Rosenberger, Carolyn Menendez, Lars J. Grimm, Akiko Chiba, & Jennifer K. Plichta (2025). High risk surveillance MRI may not be necessary in BRCA1/2 mutation carriers over 70 years old. Breast Cancer Research and Treatment. https://doi.org/10.1007/s10549-025-07657-y
Astrid Botty van den Bruele, et al. “High risk surveillance MRI may not be necessary in BRCA1/2 mutation carriers over 70 years old.” Breast Cancer Research and Treatment, 2025. doi:10.1007/s10549-025-07657-y.
@article{Bruele2025,
title = {High risk surveillance MRI may not be necessary in BRCA1/2 mutation carriers over 70 years old},
author = {Bruele, Astrid Botty van den and Ren, Yi and Thomas, Samantha M. and Ntowe, Koumani W. and Rosenberger, Laura H. and Menendez, Carolyn and Grimm, Lars J. and Chiba, Akiko and Plichta, Jennifer K.},
journal = {Breast Cancer Research and Treatment},
year = {2025},
doi = {10.1007/s10549-025-07657-y},
url = {https://doi.org/10.1007/s10549-025-07657-y}
}